Synerkine Pharma: Funding, Investors & Team (Sep 2026)
Synerkine Pharma specializes in creating innovative fusion proteins to alleviate inflammatory, neuropathic, and osteoarthritic pain. By targeting shared regulatory mechanisms involved in various forms of chronic pain, these proteins possess distinctive characteristics that allow patients to effectively manage pain in several pre-clinical models.
Synerkine Pharma has raised $5.6M across 1 funding round on record, the most recent a Series A of $5.6M announced in Oct 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Synerkine Pharma Company Profile and Key Stats
Latest funding round on record: Oct 2023.
Synerkine Pharma Funding Rounds
Synerkine Pharma Founders and Leadership Team
Contact details for the Synerkine Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Synerkine Pharma Funding Compared to Other Biotechnology Startups
Synerkine Pharma's latest round of $5.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synerkine Pharma in Biotechnology and Utrecht
Companies Similar to Synerkine Pharma
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Synerkine Pharma Funding FAQs
What does Synerkine Pharma do?
Synerkine Pharma specializes in creating innovative fusion proteins to alleviate inflammatory, neuropathic, and osteoarthritic pain. By targeting shared regulatory mechanisms involved in various forms of chronic pain, these proteins possess distinctive characteristics that allow patients to effectively manage pain in several pre-clinical models.
How much funding has Synerkine Pharma raised?
Synerkine Pharma has raised $5.6M across 1 round on record. The most recent is a Series A of $5.6M announced in Oct 2023.
When did Synerkine Pharma last raise funding?
Synerkine Pharma's most recent funding round on record is a Series A of $5.6M, announced in Oct 2023.
Who is the CEO of Synerkine Pharma?
Hans Preusting is listed as CEO at Synerkine Pharma.
Where is Synerkine Pharma headquartered?
Synerkine Pharma is based in Utrecht, Netherlands.
How many employees does Synerkine Pharma have?
Synerkine Pharma is in the 1-10 employee band.
How does Synerkine Pharma's funding compare to other Biotechnology startups?
Synerkine Pharma's latest round of $5.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Synerkine Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synerkine Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.